Women with postmenopausal osteoporosis at high risk for fracture,
TYMLOS was proven to reduce the risk of spinal fractures by 86% in postmenopausal women with osteoporosis.
(0.6% of women taking TYMLOS had a fracture vs 4.2% taking placebo.)
Do you want to make lowering the risk of fracture a priority?
You may be at risk for fracture from postmenopausal osteoporosis if you:
- Have had an osteoporotic fracture
- Have other risk factors such as tobacco use, alcohol use (more than 2 drinks per day) or a family history of osteoporosis
- Are taking other drugs that could affect bone health
- Did not do well on, or could not tolerate, other osteoporosis medications
Download the Discussion Guide and talk to your doctor about
Created for women with osteoporosis
at high risk for fracture after menopause
TYMLOS is a daily injection with a pen.
The pen needle is about the length of an eyelash.
After first use no refrigeration is required, so you can take it with you for up to 30 days at room temperature.
The pen has enough medicine in it for 30 days.
You could pay $4 a month for TYMLOS
Commercially insured patients may be eligible* for savings support — and may pay as little as $4 a month.
*Eligibility rules and restrictions apply.
Show off your
osteoferocious side
Are you taking TYMLOS? Your story could help other women with postmenopausal osteoporosis. We’d love to hear from you!
What is the most important information I should know about TYMLOS?
TYMLOS may cause serious side effects including: Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma. It is not known if people who take TYMLOS will have a higher chance of getting osteosarcoma. READ MORE
What is the most important information I should know about TYMLOS?
TYMLOS may cause serious side effects including: Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma. It is not known if people who take TYMLOS will have a higher chance of getting osteosarcoma. READ MORE
You are leaving this site
You are now leaving TYMLOS.com, a website of Radius Health. Links to all third-party websites are provided as a resource to our visitors. We are not responsible for the contents or reliability of any third-party websites to which we provide a link.
For US residents only.
© 2018 Radius Health, Inc. All rights reserved.
6/18. TYM-US-01599
